Recent developments in screening, diagnosis and surgical treatment of hepatocellular carcinoma

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 223, 1997, Pages 50-54

  Ijzermans, J N M ^a   Bac, D J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Hepatocellular carcinoma; Liver transplantation; Resection; Screening; Ultrasound

Indexed keywords

ALPHA FETOPROTEIN;

ALGORITHM; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; PRIORITY JOURNAL; VIRUS HEPATITIS; LIVER TUMOR; REVIEW; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; RISK FACTORS;

EID: 0030632303     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Imaeda T, Yamawaki Y, Goto H, Seki M, Linuma G, Kanematsu M, et al. Growth kinetics of small hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1993;5:739-44.
2. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsucani S, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology 1986;90:289-98.
3. Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltigirone M, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. Gastroenterology 1989;96:1566-71.
4. Chen DS, Sung JL. Serum alphafetoprotein in hepatocellular cancer. Cancer 1977;40:779-83.
5. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
6. Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994;21:1029-34.
7. Propst T, Propst A, Dietz O, Judmaier G, Braunsteiger H, Vogel W, et al. Prevalence of hepatocellular carcinoma alpha-1-antitrypsin deficiency. J Hepatol 1994;21:1006-11.
8. Esquivel CO, Gutierrez C, Cox KL, Garcia-Kennedy R, Berquist W, Concepion W, et al. Hepatocellular carcinoma and liver cell dysplasia in children with chronic liver disease. J Pediatr Surg 1994;29:1465-9.
9. Siersema PD, ten Kate FJ, Mulder PG, Wilson JH. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992;12(2):56-61.
10. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizogucay Y, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-7.
11. Maringhini A, Cottone M, Sciarrino E, Marceno MP, La Seta F, Fusco G, et al. Ultrasonography and alpha fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci 1988;33:47-51.
12. Badia PH, Payer JL, Combis JM, Vinal JP, Pascal T. Screening for hepatocellular carcinoma in well compensated cirrhotic patients. Gastroenterology 1992;102:A777.
13. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
14. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
15. Dumas O, Barthelemy C, Audigier JC. Faut-il depister les carcinomes hépatocellulaires sur cirrhose? Gastroenterol Clin Biol 1990;14:715-26.
16. Lok ASF, Lai CL. Alpha fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989;9:110-5.
17. Dodd, 3rd GD, Miller WJ, Baron RL, Skolnick ML, Campbell WL. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR Am J Roentgenol 1992;159:727-33.
18. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 1990;155:49-54.
19. Miller WJ, Baron RI, Dodd GD, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994;1993(3):645-50.
20. Hollet MD, Jeffrey, Jr RB, Nino-Murcia M, Jorgensen MJ, Harris DP. Dual-phase helical CT of the liver: value of arterial phase scans in detection of small (<1.5 cm) malignant hepatic neoplasms. Am J Roentgenol 1995;164:879-84.
21. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. Am J Roentgenol 1994;163:323-31.
22. Oliver JH, Baron RL, Dodd GD, Peterson MS, Carr BI. Does advanced cirrhosis with portosystemic shunting affect the value of CT arterial portography in the evaluation of the liver. Am J Roentgenol 1995;164(2):333-7.
23. Freeny PC, Marks WM. Hepatic perfusion abnormalities during CT angiography: detection and interpretation. Radiology 1986;159:685-91.
24. Merine D, Takayasu Wakao F. Detection of hepatocellular carcinoma: comparison of CT during arterial portography with CT after intraarterial injection of iodized oil. Radiology 1990;175:707-10.
25. Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Hatanaka Y, Murakami R, et al. Hepatocellular carcinoma in cirrhotic livers; detection with unenhanced and iron-oxide enhanced MR imaging. Radiology 1995;195:106-12.